Status:

COMPLETED

Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract

Lead Sponsor:

Centre Antoine Lacassagne

Conditions:

Head and Neck Cancer

Infection

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

RATIONALE: It is not yet known which regimen of enteral nutrition is more effective in preventing infections in patients undergoing surgery for cancer of the upper aerodigestive tract. PURPOSE: This ...

Detailed Description

OBJECTIVES: Primary * Determine the efficacy of immunonutrition (IMPACT®) in patients with de novo cancer of the upper aerodigestive tract. Secondary * Determine the best time to initiate treatmen...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Diagnosis of de novo cancer of the upper aerodigestive tract, including the following:
  • Oral cavity
  • Larynx
  • Oropharynx
  • Hypopharynx
  • Planned surgical excision of tumors with opening of the mucous membranes, with or without immediate reconstruction by myocutaneous pedicle flap or free-bone graft
  • Planned adjuvant enteral nutritional regimen lasting at least 7 days post-operatively
  • PATIENT CHARACTERISTICS:
  • ANC \> 1.8 x 10\^9/L
  • Hemoglobin \> 9 g/dL
  • Transaminases ≤ 3 times upper limit of normal (ULN)
  • Bilirubin ≤ 3 times ULN
  • Creatinine 70-250 μmol/L
  • Urea ≤ 1.5 times ULN
  • Glucose \< 1.5 g/L
  • Sodium \< 145 mmol/L
  • Not pregnant or nursing
  • Fertile patients must use effective contraception
  • No psychological, social, geographical, or familial reasons prohibiting follow-up
  • No insulin-dependent diabetes
  • No severe psychiatric illness
  • PRIOR CONCURRENT THERAPY:
  • No head and neck surgery for cancer within the past year
  • No prior oral components of immunonutrition
  • No prior neoadjuvant chemotherapy
  • No prior radiotherapy to head and neck

Exclusion

    Key Trial Info

    Start Date :

    July 1 2007

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2011

    Estimated Enrollment :

    311 Patients enrolled

    Trial Details

    Trial ID

    NCT00765440

    Start Date

    July 1 2007

    End Date

    April 1 2011

    Last Update

    September 30 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Centre Antoine Lacassagne

    Nice, France, 06189